A randomized, open-label, phase 3 study of ZL-1310, a DLL3 antibody-drug conjugate (ADC), compared to investigator’s choice therapy in participants with relapsed small cell lung cancer (DLLEVATE).Afshin Dowlati, Luis Paz-Ares Rodríguez, Renke Zhou et al.|Journal of Clinical Oncology|2026Cited by 1
Identifying factors and predicting mental health issues in polypharmacy elderly using machine learning: a study based on the English longitudinal study of agingHongju Wang, Chun Liu, Hu Wei et al.|Frontiers in Psychology|2026Cited by 0
Photo-Fenton-Like(Trideutero)methylsulfonylation/Remote(Benzo)thiazolyl Migration Cascade of Unactivated Alkenes with DMSO(- <i>d</i> 6)Q F Liu, Yan Wu, H L Liu et al.|Organic Letters|2026Cited by 0